Oneness Biotech Statistics
Total Valuation
Oneness Biotech has a market cap or net worth of TWD 71.81 billion. The enterprise value is 65.15 billion.
Market Cap | 71.81B |
Enterprise Value | 65.15B |
Important Dates
The next estimated earnings date is Friday, November 8, 2024.
Earnings Date | Nov 8, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Oneness Biotech has 477.12 million shares outstanding. The number of shares has increased by 1.75% in one year.
Shares Outstanding | 477.12M |
Shares Change (YoY) | +1.75% |
Shares Change (QoQ) | +0.09% |
Owned by Insiders (%) | 7.82% |
Owned by Institutions (%) | 4.71% |
Float | 314.58M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | 5.32 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -66.56 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -155.43 |
Financial Position
The company has a current ratio of 45.27, with a Debt / Equity ratio of 3.05.
Current Ratio | 45.27 |
Quick Ratio | 44.25 |
Debt / Equity | 3.05 |
Debt / EBITDA | n/a |
Debt / FCF | -1.02 |
Interest Coverage | -134.24 |
Financial Efficiency
Return on equity (ROE) is -6.83% and return on invested capital (ROIC) is -4.71%.
Return on Equity (ROE) | -6.83% |
Return on Assets (ROA) | -4.59% |
Return on Capital (ROIC) | -4.71% |
Revenue Per Employee | 2.37M |
Profits Per Employee | -22.76M |
Employee Count | 43 |
Asset Turnover | 0.01 |
Inventory Turnover | 0.45 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -11.72% in the last 52 weeks. The beta is 1.59, so Oneness Biotech's price volatility has been higher than the market average.
Beta (5Y) | 1.59 |
52-Week Price Change | -11.72% |
50-Day Moving Average | 154.71 |
200-Day Moving Average | 160.72 |
Relative Strength Index (RSI) | 45.86 |
Average Volume (20 Days) | 2,172,178 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Oneness Biotech had revenue of TWD 101.93 million and -978.89 million in losses. Loss per share was -2.06.
Revenue | 101.93M |
Gross Profit | 49.15M |
Operating Income | -1.11B |
Pretax Income | -976.51M |
Net Income | -978.89M |
EBITDA | -684.27M |
EBIT | -1.11B |
Loss Per Share | -2.06 |
Balance Sheet
The company has 7.54 billion in cash and 425.90 million in debt, giving a net cash position of 7.12 billion or 14.92 per share.
Cash & Cash Equivalents | 7.54B |
Total Debt | 425.90M |
Net Cash | 7.12B |
Net Cash Per Share | 14.92 |
Equity (Book Value) | 13.95B |
Book Value Per Share | 28.27 |
Working Capital | 7.64B |
Cash Flow
In the last 12 months, operating cash flow was -342.85 million and capital expenditures -76.32 million, giving a free cash flow of -419.18 million.
Operating Cash Flow | -342.85M |
Capital Expenditures | -76.32M |
Free Cash Flow | -419.18M |
FCF Per Share | -0.88 |
Margins
Gross Margin | 48.22% |
Operating Margin | -1,087.36% |
Pretax Margin | -958.06% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | -411.25% |
Dividends & Yields
Oneness Biotech does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | 1 |
Payout Ratio | n/a |
Buyback Yield | -1.75% |
Shareholder Yield | -1.75% |
Earnings Yield | -1.37% |
FCF Yield | -0.58% |
Stock Splits
The last stock split was on July 26, 2024. It was a forward split with a ratio of 1.049967976.
Last Split Date | Jul 26, 2024 |
Split Type | Forward |
Split Ratio | 1.049967976 |